Education
About Us
Working with TipRanks
Follow Us
Dr. Reddy's Laboratories Ltd. (IN:DRREDDY)
:DRREDDY
Earnings Data
Report Date
Jan 23, 2026Before Open (Confirmed)
Period Ending
2026 (Q3)Consensus EPS Forecast
14.1Last Year’s EPS
16.94Same Quarter Last Year
Moderate Sell
Based on 3 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook for Dr. Reddy's Laboratories. While there was strong revenue growth driven by emerging markets and the India business, challenges in the U.S. generics market and declining profit margins posed concerns. Regulatory hurdles also added to the complexity of the business environment.Company Guidance
Steady Revenue Growth
Consolidated revenue for the quarter stood at INR 8,805 crores (USD 992 million), a growth of 9.8% year-over-year and 3% on a sequential basis. The acquired consumer healthcare business supported this growth.
Emerging Markets Performance
Emerging market business delivered revenue of INR 1,655 crores in Q2, reflecting a growth of 14% year-on-year and 18% sequentially, driven by new product launches and favorable ForEx.
Strong India Business Growth
India business reported revenues of INR 1,578 crores in Q2, delivering a double-digit year-on-year growth of 13% and a 7% increase sequentially, driven by new product launches and improved pricing.
ESG Achievements
Dr. Reddy's retained its MSCI ESG Rating of A for the second consecutive year, and its ESG Risk Rating from Morningstar Sustainalytics improved from 23.6% to 18.4%.
Dr. Reddy's Laboratories Ltd. (IN:DRREDDY) Earnings, Revenues Date & History
IN:DRREDDY Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
IN:DRREDDY Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Oct 24, 2025 | ₹1279.85 | ₹1284.00 | +0.32% |
Jul 23, 2025 | ₹1240.40 | ₹1247.55 | +0.58% |
May 09, 2025 | ₹1141.46 | ₹1149.11 | +0.67% |
Jan 23, 2025 | ₹1288.13 | ₹1281.22 | -0.54% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Dr. Reddy's Laboratories Ltd. (IN:DRREDDY) report earnings?
Dr. Reddy's Laboratories Ltd. (IN:DRREDDY) is schdueled to report earning on Jan 23, 2026, Before Open (Confirmed).
What is Dr. Reddy's Laboratories Ltd. (IN:DRREDDY) earnings time?
Dr. Reddy's Laboratories Ltd. (IN:DRREDDY) earnings time is at Jan 23, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Dr. Reddy's Laboratories Ltd. stock?
The P/E ratio of Dr. Reddy's Laboratories Ltd. is N/A.
What is IN:DRREDDY EPS forecast?
IN:DRREDDY EPS forecast for the fiscal quarter 2026 (Q3) is 14.1.